Disetronic expects to beat own forecast of 30% sales rise in fiscal 1997
This article was originally published in Clinica
Executive Summary
Swiss drug delivery company Disetronic expects to exceed the rise in sales predicted at the time of its flotation in June. In the 12 months to March 1997, the company had expected sales to increase by 30% to SwFr 108 million ($85 million).